Maplight Therapeutics, Inc. · NASDAQ:MPLT

Catalyst4, Inc. reported a 47.90% stake in Maplight Therapeutics, Inc. (Schedule 13D/A)

Event Jul 30, 2026 · Filed Aug 3, 2026

Catalyst4, Inc. reported a 47.90% stake in Maplight Therapeutics, Inc., 20,906,689 shares, with active intent on Jul 30, 2026. Filed Aug 3, 2026 (Schedule 13D/A).

Stake
47.90%
Shares
20,906,689
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Catalyst4, Inc.47.90%20,906,689
Robert Brown47.90%20,906,689
Ekemini Riley47.90%20,906,689
Mark Vorsatz47.90%20,906,689

Source

View original at SEC

Related